These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 30683678)

  • 1. Primary membranous nephropathy: comprehensive review and historical perspective.
    Keri KC; Blumenthal S; Kulkarni V; Beck L; Chongkrairatanakul T
    Postgrad Med J; 2019 Jan; 95(1119):23-31. PubMed ID: 30683678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Membranous nephropathy: New insights in therapeutic approach].
    Dahan K
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S83-S87. PubMed ID: 28577748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor.
    Jatem Escalante E; Segarra Medrano A; Carnicer Cáceres C; Martín-Gómez MA; Salcedo Allende MT; Ostos Roldan H; Agraz Pamplona I
    Nefrologia; 2015; 35(5):479-86. PubMed ID: 26306972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Membranous glomerulonephritis (MGN), ongoing studies].
    La Manna G; Baraldi O; Cunia V; Corradetti V; Aiello V; Busutti M; Gasperoni L; Spazzoli A; Comai G
    G Ital Nefrol; 2017 Sep; 34(5):113-118. PubMed ID: 28963832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab.
    Boyer-Suavet S; Andreani M; Lateb M; Savenkoff B; Brglez V; Benzaken S; Bernard G; Nachman PH; Esnault V; Seitz-Polski B
    Front Immunol; 2019; 10():3069. PubMed ID: 31998325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment of primary membranous nephropathy in 2016.
    van de Logt AE; Hofstra JM; Wetzels JF
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1463-1478. PubMed ID: 27535699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent Membranous Nephropathy After Kidney Transplantation Associated With Phospholipase A2 Receptor and Successfully Treated With Rituximab: A Case Report.
    Ishiwatari A; Wakai S; Shirakawa H; Honda K
    Transplant Proc; 2018 Oct; 50(8):2565-2568. PubMed ID: 30316399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic membranous nephropathy in children treated with rituximab: report of two cases.
    Malatesta-Muncher R; Eldin KW; Beck LH; Michael M
    Pediatr Nephrol; 2018 Jun; 33(6):1089-1092. PubMed ID: 29546599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Membranous nephropathy: Pathophysiology and natural history].
    Seitz-Polski B; Lambeau G; Esnault V
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S75-S81. PubMed ID: 28577747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of primary membranous nephropathy: where are we now?
    Angioi A; Lepori N; López AC; Sethi S; Fervenza FC; Pani A
    J Nephrol; 2018 Aug; 31(4):489-502. PubMed ID: 28875476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma exchange and rituximab treatments in primary membranous nephropathy combined with crescentic glomerulonephritis: A case report.
    Lu H; Cui Z; Zhou XJ; Jin QZ; Yu XJ; Wang SX; Wang Y; Zhou FD; Zhao MH
    Medicine (Baltimore); 2019 May; 98(18):e15303. PubMed ID: 31045764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membranous Nephropathy: Core Curriculum 2021.
    Alsharhan L; Beck LH
    Am J Kidney Dis; 2021 Mar; 77(3):440-453. PubMed ID: 33487481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membranous Nephropathy: Approaches to Treatment.
    Bomback AS; Fervenza FC
    Am J Nephrol; 2018; 47 Suppl 1():30-42. PubMed ID: 29852477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membranous nephropathy: A ten-year journey of discoveries.
    Cai Q; Hendricks AR
    Semin Diagn Pathol; 2020 May; 37(3):116-120. PubMed ID: 32061439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipase A2 receptor positive membranous nephropathy long after living donor kidney transplantation between identical twins.
    Saito H; Hamasaki Y; Tojo A; Shintani Y; Shimizu A; Nangaku M
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():101-4. PubMed ID: 26031599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: protocol of a pilot randomised controlled trial.
    Scolari F; Dallera N; Gesualdo L; Santoro D; Pani A; Santostefano M; Feriozzi S; Mani LY; Boscutti G; Messa P; Magistroni R; Quaglia M; Ponticelli C; Ravani P
    BMJ Open; 2019 Dec; 9(12):e029232. PubMed ID: 31806605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Membranous nephropathy: Diagnosis, new insights in pathophysiology, and therapeutic approach].
    Dahan K
    Rev Med Interne; 2016 Oct; 37(10):674-679. PubMed ID: 27236434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of membranous nephropathy: time for a paradigm shift.
    Ruggenenti P; Fervenza FC; Remuzzi G
    Nat Rev Nephrol; 2017 Sep; 13(9):563-579. PubMed ID: 28669992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiopathic membranous nephropathy preceding membranous lupus nephritis: a case report.
    Gökalp C; Aygun G; Dogan AF; Usta U; Kurultak I; Ustundag S
    Lupus; 2020 Mar; 29(3):340-343. PubMed ID: 31918602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membranous nephropathy: the start of a paradigm shift.
    Herrmann SM; Sethi S; Fervenza FC
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):203-10. PubMed ID: 22240444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.